(Q33990595)

30 July 2017

1 reference

title

Cholangiocarcinoma. (English)

1 reference

30 July 2017

0 references

Simon D Taylor-Robinson

series ordinal

object named as

Simon D Taylor-Robinson

1 reference

30 July 2017

Shahid A Khan

1 reference

30 July 2017

Howard C Thomas

series ordinal

1 reference

30 July 2017

Brian R Davidson

series ordinal

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

30 July 2017

1 reference

30 July 2017

volume

366

1 reference

30 July 2017

issue

9493

1 reference

30 July 2017

page(s)

1303-1314

1 reference

A review and update on cholangiocarcinoma

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Liver, gallbladder, extrahepatic bile ducts, and pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

The epidemiology of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Worldwide trends in mortality from biliary tract malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Recent advances in the management of cholangiocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

New p53 mutations in hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Malignancies of the biliary tree

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Liver fluke-associated cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Cholangiocarcinoma in patients with opisthorchiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Choledochal cyst disease. A changing pattern of presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Carcinoma arising in choledochocele

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

FIC1 disease: a spectrum of intrahepatic cholestatic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

BSEP: function and role in progressive familial intrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Hepatolithiasis associated with cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Thorotrast-induced cholangiocarcinoma: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

The molecular pathogenesis of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Serum and bile markers for cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Surgical management of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Diagnosis and treatment of cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Elevated serum levels of tumor marker CA19-9 in acute cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Imaging of the hepatobiliary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Intrahepatic peripheral cholangiocarcinoma: CT evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Magnetic resonance imaging of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Endoscopic management of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Usefulness of 18 F-FDG PET in intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

FDG PET in the diagnosis of hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Management Strategies in Resection for Hilar Cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Role of laparoscopy in the evaluation of biliary tract cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Management of Proximal cholangiocarcinomas by surgical resection and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Improved survival in resected biliary malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Surgical treatment in proximal bile duct cancer. A single-center experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Outcome of treatment for distal bile duct cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987-1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Changing strategies in diagnosis and management of hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Liver transplantation for cholangiocarcinoma: results in 207 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Is liver transplantation indicated for cholangiocarcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Liver transplantation for unresectable perihilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Photodynamic therapy for cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Endoscopic Stenting for Malignant Biliary Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Biliary Wallstent endoprosthesis in malignant hilar obstruction: long-term results with regard to the type of obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Endoscopic biliary therapy using the combined percutaneous and endoscopic technique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967530-7

7 January 2021

10.1016/S0140-6736(05)67530-7

Identifiers

DOI

1 reference

30 July 2017

1 reference